| 2471 |
PITOBRUNIB |
PIRTOBRUTINIB 50 MG |
FILM-COATED TABLETS |
BOTTLE |
TREATMENT OF ADULT PATIENTS WITH RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA AFTER AT LEAST TWO LINES OF SYSTEMIC THERAPY, INCLUDING A BTK INHIBITOR |
NULL |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAOS |
CERTIFICATE RELEASED |
11 L 1252/24 |
04-DEC-2024 |
03-DEC-2029 |
View |
| 2472 |
REMETIRO |
RESMETIROM 100 MG |
FILM-COATED TABLETS |
BOTTLE |
INDICATED IN CONJUNCTION WITH DIET AND EXCERCISE FOR THE TREATMENT OF ADULT WITH NONCIRRHOTIC NONALCOHOLIC STEATOHEPATITIS WITH MODERATE TO ADVANCED LIVER FIBROSIS |
NULL |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAO PDR |
CERTIFICATE RELEASED |
11 L 1253/24 |
04-DEC-2024 |
03-DEC-2029 |
View |
| 2473 |
REMETIRO |
RESMETIROM 80 MG |
FILM-COATED TABLETS |
BOTTLE |
INDICATED IN CONJUNCTION WITH DIET AND EXCERCISE FOR THE TREATMENT OF ADULT WITH NONCIRRHOTIC NONALCOHOLIC STEATOHEPATITIS WITH MODERATE TO ADVANCED LIVER FIBROSIS |
NULL |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAO PDR |
CERTIFICATE RELEASED |
11 L 1254/24 |
04-DEC-2024 |
03-DEC-2029 |
View |
| 2474 |
REMETIRO |
RESMETIROM 60 MG |
FILM-COATED TABLETS |
BOTTLE |
INDICATED IN CONJUNCTION WITH DIET AND EXCERCISE FOR THE TREATMENT OF ADULT WITH NONCIRRHOTIC NONALCOHOLIC STEATOHEPATITIS WITH MODERATE TO ADVANCED LIVER FIBROSIS |
NULL |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAO PDR |
CERTIFICATE RELEASED |
11 L 1255/24 |
04-DEC-2024 |
03-DEC-2029 |
View |
| 2475 |
SEMAGLUTIDE |
SEMAGLUTIDE 14 MG |
TABLET |
BOTTLE |
TREATMENT OF TYPE 2 DIABETES MELLITUS |
NULL |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAOS |
CERTIFICATE RELEASED |
08 L 1178/24 |
21-AUG-2024 |
20-AUG-2027 |
View |
| 2476 |
SEMAGLUTIDE |
SEMAGLUTIDE 7 MG |
TABLET |
BOTTLE |
TREATMENT OF TYPE 2 DIABETES MELLITUS |
NULL |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAOS |
CERTIFICATE RELEASED |
08 L 1179/24 |
21-AUG-2024 |
20-AUG-2027 |
View |
| 2477 |
SORANNI |
SORAFENIB TOSYLATE 200 MG |
FILM-COATED TABLETS |
BOTTLE |
SORANNI IS USED TO TRET LIVER CANCER (HEPATOCELLULAR CARCINOMA), SORANNI IS ALSO USED TO TREAT KIDNEY CANCER |
NULL |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 0700/16 |
28-JUN-2023 |
27-JUN-2026 |
View |
| 2478 |
SOTORAIB |
SOTORASIB 120 MG |
FILM COATED TABLET |
BOTTLE |
TREATMENT OF NON-SMALL CELL LUNG CANCER IN ADULTS |
NULL |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAOS |
CERTIFICATE RELEASED |
07 L 0986/23 |
04-JUL-2023 |
03-JUL-2026 |
View |
| 2479 |
TADA |
TADALAFIL 20 MG, DAPOXETINE 30 MG |
FILM COATED TABLET |
BLISTERPACK |
TREATMENT OF ERECTILE DYSFUNCTION |
NULL |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAOS |
CERTIFICATE RELEASED |
11 L 1239/24 |
13-NOV-2024 |
12-NOV-2029 |
View |
| 2480 |
TADALAFEI |
TADALAFIL 20 MG |
FILM COATED TABLET |
BOTTLE |
TREATMENT FOR PULMONARY ARTERIAL HYPERTENSION IN ADULTS AND IN CHILDREN AGED 2 YEARS AND ABOVE |
NULL |
TONGMENG( LAO) PHARMACEUTICAL CO.LTD |
TONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD |
LAOS |
CERTIFICATE RELEASED |
06 L 1358/25 |
17-JUN-2025 |
16-JUN-2030 |
View |
